Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 USD | +0.31% | +0.78% | -6.58% |
01:51am | J&J-backed Rapport Therapeutics raises $136 mln in US IPO | RE |
Jun. 06 | Citigroup Adjusts Price Target on Johnson & Johnson to $180 From $185, Keeps Buy Rating | MT |
Official Publications
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Official Publications